Nachrichten zur Teva Pharmaceutical Industries Limited Aktie

Whistleblower Sues SEC For Dragging Its Feet On Reward Payout

A whistleblower in an FCPA case involving Teva Pharmaceuticals is now taking the SEC to federal court, claiming that the agency…

Teva (TEVA) Q1 Earnings Beat, Copaxone Drags Sales Down

Teva Pharmaceutical (TEVA) beats estimates for earnings but misses the same for sales. Blockbuster drug Copaxone sales continue to erode…

Teva CEO unsure about 2020 growth

When Kåre Schultz assumed office in 2017, he earmarked 2020 as the year Teva would return to growth. Now he…

Teva-Gewinn sinkt um ein Drittel

Börsen-Zeitung, 3.5.2019 Reuters/scd Tel Aviv/Frankfurt - Der weltgrößte Generikahersteller Teva Pharmaceutical leidet weiterhin unter dem Preisdruck im US-a ......…

Teva Pharmaceutical Industries Ltd (TEVA) CEO Kare Schultz on Q1 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Declining sales of blockbuster drug drag Teva revenue lower

Declining sales of blockbuster drug Copaxone dragged down first-quarter revenue at Teva Pharmaceuticals Industries Ltd....…

UPDATE 3-Tevas new migraine drug helps to contain profit fall

* Company reiterates 2019 outlook (Adds details on EpiPen, updates share price)...…

Teva Pharmaceutical Industries Limited (TEVA) Q1 2019 Earnings Call Transcript

TEVA earnings call for the period ending March 31, 2019....…

Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround

Um den gesamten Artikel unter realmoney.thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 2-Teva migraine drug helps to contain profit fall

* Company reiterates 2019 outlook (Adds quotes from CEO, details, share reaction)...…

Teva Pharmaceutical Industries Limited 2019 Q1 - Results - Earnings Call Slides

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Generic drugmaking giant Teva beats earnings estimates

Um den gesamten Artikel unter bloom.bg zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Israels Teva Pharm Q1 profit falls slightly less than forecast

Israel-based Teva Pharmaceutical Industries reported a slightly smaller-than-expected drop in first-quarter profit on Thursday and said it was on track to cut $3…

Teva Q1 revenue down 15% but beats analysts on profit

With a slump in revenue from Copaxone and respiratory products and a fall in US generic sales, better than expected…

Teva stock up 2% after company beats on earnings but misses on revenue

Shares of Teva Pharmaceuticals Industries Ltd. rose 2% in premarket trade Thursday after the drugmaker reported first-quarter earnings that…

Israels Teva Pharm Q1 profit falls slightly less than forecast

Israel-based Teva Pharmaceutical Industries reported a slightly smaller-than-expected drop in first-quarter profit on Thursday and said it was on track to cut $3…

FIMI completes acquisition of Tevas Kiryat Shmona plant

FIMI Opportunity Funds, headed by Ishay Davidi, has completed the acquisition of the Migada plant in Kiryat Shmona from Teva…

The obscure advisory committees at the heart of the U.S. drug pricing debate

Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co…

Teva (TEVA) to Report Q1 Earnings: Whats in the Cards-

Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to hurt Tevas (TEVA) sales…

The Daily Biotech Pulse: Mixed Results For Mercks Keytruda In Stomach Cancer; Roches Spark-Buy Delayed, Teva Recalls Hypertension Drug

Heres a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week…

Teva Pharmaceuticals USA recalls Losartan Potassium 25mg and 100mg Tablets USP sold exclusively to Golden State Medical Supply

This recall is due to the detection of an impurity - N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) - found in six lots of…

Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know

In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $15.14, marking a +0.93% move from the previous…

Teva to discontinue ENFORCE program for fremanezumab due to futility

The Israeli pharma came to the decision after a pre-specified futility analysis showed that fremanezumab was unlikely to meet the…

Teva Continues To Be Oversold And Undervalued

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva abandons fremanezumab cluster headache trial

An analysis of the Phase III study in episodic cluster headache revealed that the study’s primary endpoint is unlikely to…

UPDATE 2-Teva stops testing its migraine drug as cluster headache treatment

Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the company found…

UPDATE 1-Teva scraps cluster headache program

Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches....…

Teva to stop developing cluster headache treatment

Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches....…

Teva launches generic version of VESIcare (solifenacin succinate) tablets in US

Solifenacin Succinate Tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence,…

Teva launches generic overactive bladder treatment

Solifenacin Succinate tablets treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency....…

Options bulls bet on pharma & tech

"Halftime Report" trader Jon Najarian spots unusual options activity in shares of Teva Pharma & Box....…

FDA approves Teva opioid antidote nasal spray

This is the first generic version of the nasal spray that can reverse the effects of opioid overdose that the…

U.S. FDA approves Tevas generic nasal spray to treat opioid overdose

Generic drugmaker Teva Pharmaceutical Industries Ltd on Friday received approval from the U.S. Food and Drug Administration (FDA) to market its generic nasal…

Teva Gets Approval to Sell Generic Nasal Spray for Opioid Overdoses

The U.S. Food and Drug Administration gave Teva Pharmaceutical the go-ahead to market a generic naloxone nasal spray to treat…

Top Teva execs paid double in 2018 as share fell 18%

The five top earners were paid $55.9 million in 2018, almost double the $28.8 million that the five most senior…

Teva: Heres Why The Future Is Different For This Troubled Pharmaceutical Giant

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Der weltgrösste Generikahersteller Mylan wagt sich mit Verspätung in den Schweizer Markt

Der US-Konzern Mylan will den beiden dominierenden Anbietern Sandoz und Teva Marktanteile abjagen. Er verspricht zugleich, einen Beitrag zu einer…

Teva rebrands to raise consumer awareness

Only 2% of patients worldwide know about the Israeli pharmaceutical company, even though it has 200 million daily users....…

Teva signs $2.3b credit facility deal

The new $2.3 billion unsecured revolving credit facility will replace the companys existing $3 billion credit facility....…

Tevas Returning To EPS Growth In 2020 Looks Solid

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Kicks Off Festival Season With The Outpost Tour

GOLETA, Calif. , April 8, 2019 /PRNewswire/ --  Teva® ,…

Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU

Novartis (NVS) announces plans to acquire IFM Tre, a subsidiary of IFM Therapeutics focused on anti-inflammatory drugs. Pfizer (PFE) &…

RPT-Oklahoma drops several claims in opioid case against J&J, Teva

Oklahomas attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical Industries Ltd in…

Oklahoma drops several claims in opioid case against J&J, Teva

Oklahomas attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical Industries Ltd in…

Teva Announces Collaboration with Publish Brand for Spring 2019

GOLETA, Calif. , April 3, 2019 /PRNewswire/ --  Teva ®,…

Tevas Anti-CGRP Injection Ajovy Gets Approval in Europe

Tevas (TEVA) CGRP injection, Ajovy gets marketing approval in the EU after securing approval in the United States last year....…

Tevas migraine treatment AJOVY receives EU approval

AJOVY is a humanized monoclonal antibody (mAb) that binds to the calcitonin gene-related peptide (CGRP) ligand and blocks its binding…

Teva migraine drug Ajovy wins European approval

Revenue from Ajovy, which won FDA approval in September 2018, was just $3 million last year but is expected to…

Tevas Copaxone patent upheld in Europe

The European Patent Offices decision leaves the patent on multiple sclerosis treatment Copaxone 40mg valid until 2030....…

A U.S. jury rejected a claim by Swedens Orexo that 2 generic opioid-addiction treatments created by Teva Pharmaceutical infringed on their patent

Um den gesamten Artikel unter bloom.bg zu lesen, klicken Sie bitte auf die Überschrift...…